image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Glisten - Gain to date: 174%

March 2004

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • GLI
Glisten has announced the acquisition of Fravigar, a private family-owned business, which manufactures a wide range of confectionery, including wine gums, fruit pastilles and jelly beans.  It is paying £6.5m (£6.2m cash, £0.3m shares) for the Skegness-based business, which made a pretax profit of £1.05m on turnover of £5.86m in the year ended December 2002 and is expected to have made a similar contribution last year.  Glisten has also announced revised bank facilities of £11m, which following the acquisition, will leave un-drawn headroom of £3.5m. Fravigar provides opportunities for cross-selling, given that there is little overlap in terms of customer base or product.   Other growthopportun ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X